The most significant issue associated with transdermal drug delivery is the likelihood of skin irritation caused by penetration enhancement techniques and the transdermal patch itself. Due to this, there have been models created to foresee the likelihood of skin irritation due to drug or vessel interaction using solubility and skin irritation studies using the PII test to detect rednessÂ or swelling 24 hours after administering the patch.